학술논문
Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
Document Type
article
Source
Clinical Case Reports, Vol 9, Iss 6, Pp n/a-n/a (2021)
Subject
Language
English
ISSN
2050-0904
Abstract
Abstract Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients.